Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease

Open Access

Peer-reviewed

Research Article

Marieke G. M. Weernink ,

* E-mail: m.g.m.weernink@utwente.nl

Affiliation Department of Health Technology and Services Research, MIRA institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands
⨯
Janine A. van Til,

Affiliation Department of Health Technology and Services Research, MIRA institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands
⨯
Jeroen P. P. van Vugt,

Affiliation Department of Neurology, Medical Spectrum Twente, Enschede, the Netherlands
⨯
Kris L. L. Movig,

Affiliation Department of Clinical Pharmacy, Medical Spectrum Twente, Enschede, the Netherlands
⨯
Catharina G. M. Groothuis-Oudshoorn,

Affiliation Department of Health Technology and Services Research, MIRA institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands
⨯
Maarten J. IJzerman

Affiliation Department of Health Technology and Services Research, MIRA institute for Biomedical Technology and Technical Medicine, University of Twente, Enschede, the Netherlands
⨯

Reader Comments (0)

Patients
Is the Subject Area "Patients" applicable to this article?

Thanks for your feedback.
Parkinson disease
Is the Subject Area "Parkinson disease" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.
Decision making
Is the Subject Area "Decision making" applicable to this article?

Thanks for your feedback.
Neurosurgery
Is the Subject Area "Neurosurgery" applicable to this article?

Thanks for your feedback.
Vertigo
Is the Subject Area "Vertigo" applicable to this article?

Thanks for your feedback.
Physicians
Is the Subject Area "Physicians" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.